Accelerating ASO Drug Discovery with Transparent Machine Learning and Enhanced Off-Target Prediction
View Larger More Details

Accelerating ASO Drug Discovery with Transparent Machine Learning and Enhanced Off-Target Prediction

August 25, 2025
Love0
Pharmacodynamic Biomarker Discovery for MDM2 Inhibitors
View Larger More Details

Data Compendium for MDM2 Inhibitors

July 18, 2025
Love0
DNA strands
View Larger More Details

Advanced Target Profiling in Cancer – A Spatial and Single-Cell Transcriptomics Approach

November 12, 2024
Love0
Excelra rare monogenic disease banner image
View Larger More Details

Data-Driven Solutions for Rare Monogenic Blood Disorders: Identifying and Prioritizing Treatment Compounds for Improved Patient Outcomes

August 30, 2024
Love0
Excelra case study on Rare Monogenic Blood Disorders
View Larger More Details

Empowering Client Success: Unveiling the Disease Landscape of Hyperphosphatemia

August 30, 2024
Love0
Enhancing Vegan Cheese Production: Leveraging Transcriptomic Data for Taste and Texture Improvement
View Larger More Details

Enhancing Vegan Cheese Production: Leveraging Transcriptomic Data for Taste and Texture Improvement

August 28, 2024
Love0
Optimizing Immunotherapy with Excelra's AI powered patient stratification
View Larger More Details

A Case Study On Optimizing Immunotherapy with Excelra’s AI-powered Patient Stratification

July 18, 2024
Love0
Building large Data assets allows MoA elucidation while keeping a view on competitive landscape
View Larger More Details

Building large Data assets allows MoA elucidation while keeping a view of the competitive landscape

June 10, 2024
Love0
Conquer COVID-19 Testing Challenges: In-Silico Design for Accurate NAAT Assays
View Larger More Details

Accelerating the Development of a Rapid Detection NAAT Assay for SARS-CoV2

April 24, 2024
Love0
View Larger More Details

Custom annotation of public single-cell data offers opportunities for target identification

September 5, 2023
Love0